Dr Reddy's gets EIR for Hyderabad facility
New Delhi: Drug firm Dr. Reddy's Laboratories today said it has received establishment inspection report (EIR) from the US health regulator for its custom pharmaceutical services facility at Hyderabad.
The facility had undergone audit by the United States Food and Drug Administration (USFDA), Dr. Reddy's Laboratories said in a BSE filing.
The company has received EIR from the USFDA for the facility, it added.
As per USFDA, after the completion of an inspection of a facility, an EIR is issued to a company detailing inspection findings.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd